GlassScriptPhysician profile
Jennifer Blackerby
NPI 1316287030
$1,479.03
in general payments reported to CMS, 2019-2025
16 companies · none reported in 2025
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2021: $1,028 · 2022: $378 · 2023: $35.58 · 2024: $37.28.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $72.86.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $72.86 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Janssen Pharmaceuticals, INC | $319.96 | 2021-2023 | Xarelto |
| Merck Sharp & Dohme LLC | $279.63 | 2021-2022 | |
| Novartis Pharmaceuticals Corporation | $207.44 | 2021-2022 | |
| Astellas Pharma US INC | $173.21 | 2021-2022 | |
| Astrazeneca Pharmaceuticals LP | $121.84 | 2021-2022 | |
| E.R. Squibb & Sons, L.L.C. | $74.37 | 2021 | |
| Amgen INC. | $61.88 | 2021-2022 | |
| Biotronik INC. | $59.03 | 2021 | |
| Novo Nordisk INC | $39.26 | 2022 | |
| Boehringer Ingelheim Pharmaceuticals, INC. | $34.02 | 2021 | |
| Boston Scientific Corporation | $23.82 | 2024 | Spaceoar Vue System - 10ml |
| Zoll Services LLC (A/K/A Zoll Lifecor Corp) | $22.67 | 2021-2022 | |
| Bayer Healthcare Pharmaceuticals INC. | $18.45 | 2021 | |
| Pfizer INC. | $16.24 | 2021 | |
| Kowa Pharmaceuticals America, INC. | $13.75 | 2021 |
Show all 16 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Ironshore Pharmaceuticals INC. | $13.46 | 2024 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Jennifer Blackerby listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.